Focus:

Cancer Channel Featured Story TOP

Add to Favorites Subscribe Share
fbshare-Cancer Channel Featured Story TOP

Showing results

110 of 91
Newswise: Adding Immunotherapy After Initial Treatment Can Benefit Metastatic Lung Cancer Patients
  • Embargo expired:
    11-Jul-2019 11:00 AM EDT

Article ID: 715470

Adding Immunotherapy After Initial Treatment Can Benefit Metastatic Lung Cancer Patients

Perelman School of Medicine at the University of Pennsylvania

Treating metastatic non-small cell lung cancer (NSCLC) patients with the immunotherapy drug pembrolizumab after they’ve completed locally ablative therapy almost tripled the median progression-free survival compared to the historical average.

Released:
9-Jul-2019 11:00 AM EDT
Newswise: Immunotherapy drug found safe in treating cancer patients with HIV

Article ID: 713855

Immunotherapy drug found safe in treating cancer patients with HIV

Fred Hutchinson Cancer Research Center

The results of a study led by physicians at Fred Hutchinson Cancer Research Center showed that patients living with HIV and one of a variety of potentially deadly cancers could be safely treated with the immunotherapy drug pembrolizumab, also known by its brand name, KEYTRUDA®.

Released:
3-Jun-2019 2:05 PM EDT
Newswise: Mouse Studies Show Minimally Invasive Route Can Accurately Administer Drugs to Brain
  • Embargo expired:
    1-May-2019 1:00 PM EDT

Article ID: 711911

Mouse Studies Show Minimally Invasive Route Can Accurately Administer Drugs to Brain

Johns Hopkins Medicine

In experiments in mice, Johns Hopkins researchers say they have developed a technique that facilitates the precise placement of cancer drugs at their intended targets in the brain. This approach pairs a technique that guides a catheter through the brain’s arteries with positron emission technology (PET) scans to precisely place cancer drugs at their intended targets in the brain. If future studies show this image-guided drug delivery method is safe and effective in humans, the researchers say it could improve outcomes for historically difficult-to-treat and often lethal brain cancers, such as glioblastoma.

Released:
29-Apr-2019 9:00 AM EDT
Newswise: A Resolution for Good Health

Article ID: 705827

A Resolution for Good Health

Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute experts share more about the importance of preventative screenings for colorectal and lung cancers.

Released:
26-Dec-2018 10:35 AM EST
Newswise: New research explores policies on timely breast cancer diagnosis for underserved women

Article ID: 705785

New research explores policies on timely breast cancer diagnosis for underserved women

University of Illinois at Chicago

Delays in diagnosis and use of under-resourced health centers account for most racial and ethnic disparities when it comes to a timely breast cancer diagnosis, according to a new study.

Released:
20-Dec-2018 4:05 PM EST
Newswise: Genome offers clues to esophageal cancer disparity

Article ID: 705750

Genome offers clues to esophageal cancer disparity

Michigan Medicine - University of Michigan

A change in the genome of Caucasians could explain much-higher rates of the most common type of esophageal cancer in this population, a new study finds. It suggests a possible target for prevention strategies, which preliminary work suggests could involve flavonoids derived from cranberries.

Released:
20-Dec-2018 10:05 AM EST
Newswise: Novel Biomarker Found in Ovarian Cancer Patients Can Predict Response to Therapy
  • Embargo expired:
    20-Sep-2018 11:00 AM EDT

Article ID: 700567

Novel Biomarker Found in Ovarian Cancer Patients Can Predict Response to Therapy

University of Chicago Medical Center

Researchers have identified an independent prognostic factor, cancer/testis antigen 45, that is associated with extended disease-free survival for women with advanced ovarian cancer. Patients with high levels of CT45 in their tumors lived more than seven times as long as patients who lacked sufficient CT45.

Released:
14-Sep-2018 12:05 PM EDT
Newswise: Integrated Analysis Finds Vulnerabilities to Target in a High-Risk Pediatric Tumor
  • Embargo expired:
    23-Aug-2018 11:00 AM EDT

Article ID: 699398

Integrated Analysis Finds Vulnerabilities to Target in a High-Risk Pediatric Tumor

St. Jude Children's Research Hospital

Research from the St. Jude Children’s Research Hospital—Washington University Pediatric Cancer Genome Project has revealed new vulnerabilities and leads for treatment of rhabdomyosarcoma

Released:
22-Aug-2018 4:05 PM EDT
Newswise: Like Shark Attack and the Lottery, Unconscious Bias Influences Cancer Screening

Article ID: 699162

Like Shark Attack and the Lottery, Unconscious Bias Influences Cancer Screening

University of Colorado Cancer Center

Doctors with personal experience of cancer are more likely to act against established guidelines to recommend that low-risk women receive ovarian cancer screening.

Released:
17-Aug-2018 12:15 PM EDT
Newswise: Financial Checkup Should Be Part of Health Screenings for Childhood Cancer Survivors
  • Embargo expired:
    1-Aug-2018 9:00 AM EDT

Article ID: 697944

Financial Checkup Should Be Part of Health Screenings for Childhood Cancer Survivors

St. Jude Children's Research Hospital

Adult survivors of childhood cancer should be screened for financial problems that might cause them to delay or skip medical care or to suffer psychological distress. The recommendation from St. Jude Children’s Research Hospital researchers followed an analysis that found 65 percent of survivors reported financial challenges related to their childhood cancer diagnoses. More than half of survivors (51.1 percent) indicated they worried about paying for care, and 33 percent said finances kept them from seeking medical care.

Released:
25-Jul-2018 10:35 AM EDT

Showing results

110 of 91

Chat now!